About 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide
4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide (PubChem CID 72892773) has the molecular formula C17H18N4O3
and a molecular weight of 326.36 g/mol. Its IUPAC name is 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide.
Analyze 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide?
The IUPAC name of 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide (CID 72892773) is 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide.
What is the SMILES notation for 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide?
The canonical SMILES for 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide is NC(=O)C1CN(c2ncnc3c2Cc2ccccc2OC3)CCO1.
What is the InChIKey of 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide?
The InChIKey is ODPDGMGEKDXCLA-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H18N4O3/c18-16(22)15-8-21(5-6-23-15)17-12-7-11-3-1-2-4-14(11)24-9-13(12)19-10-20-17/h1-4,10,15H,5-9H2,(H2,18,22).
What are the key properties of 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide?
4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide has a molecular weight of 326.36 g/mol, XLogP of 0.65, 2 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(5,11-dihydro-[1]benzoxepino[3,4-d]pyrimidin-1-yl)morpholine-2-carboxamide is sourced from PubChem (CID 72892773), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).